Monocytes in COVID-19: the great influencer of disease severity?
- Research Opportunity
- Masters by Research, Master of Biomedical Science
- Number of Master Places Available
- Department / Centre
- Medicine and Radiology
- Royal Melbourne Hospital
|Associate Professor Siddhartha Mahantyemail@example.com||83441972|
|Dr Louise Randallfirstname.lastname@example.org||83442181|
Summary This project will examine how monocytes respond to SARS-CoV-2 infection and the role that they play in severe COVID-19.
COVID-19 disease is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). Although the global impact of infection is still evolving, it is apparent that COVID-19 presents as a spectrum of illness ranging from mild upper respiratory tract symptoms to a multisystem inflammatory syndrome. We do not know what causes this difference in disease severity amongst individuals. Severe COVID-19 is characterised by widespread tissue injury with inflammatory changes, suggesting an important role for innate and cellular immune responses in the pathogenesis of COVID-19.
Monocytes and macrophages are crucial for an effective early immune response and the monocyte response generated can greatly influence the resolution or progression of disease in a number of settings. We have an exciting project that aims to examine the monocyte response to antigens from SARS-CoV-2 and the common coronaviruses present in the community, such as NL63.
This project will involve monocyte isolation, in vitro cell culture, cytokine measurement assays and flow cytometry.
Faculty Research Themes
School Research Themes
Masters by Research, Master of Biomedical Science
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Department / Centre
Research NodeRoyal Melbourne Hospital
MDHS Research library
Explore by researcher, school, project or topic.